Fonar Corp (FONR)
14.55
-0.71
(-4.65%)
USD |
NASDAQ |
Nov 04, 16:00
14.51
-0.04
(-0.27%)
Pre-Market: 20:00
Fonar Total Liabilities (Quarterly): 57.46M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 57.46M |
March 31, 2024 | 52.60M |
December 31, 2023 | 45.96M |
September 30, 2023 | 47.48M |
June 30, 2023 | 49.75M |
March 31, 2023 | 48.72M |
December 31, 2022 | 49.43M |
September 30, 2022 | 50.89M |
June 30, 2022 | 53.11M |
March 31, 2022 | 51.38M |
December 31, 2021 | 51.29M |
September 30, 2021 | 48.76M |
June 30, 2021 | 54.14M |
March 31, 2021 | 50.46M |
December 31, 2020 | 50.27M |
September 30, 2020 | 53.20M |
June 30, 2020 | 54.02M |
March 31, 2020 | 45.59M |
December 31, 2019 | 46.59M |
September 30, 2019 | 44.03M |
June 30, 2019 | 15.45M |
March 31, 2019 | 12.65M |
December 31, 2018 | 13.01M |
September 30, 2018 | 13.30M |
June 30, 2018 | 16.08M |
Date | Value |
---|---|
March 31, 2018 | 13.94M |
December 31, 2017 | 15.19M |
September 30, 2017 | 15.45M |
June 30, 2017 | 15.85M |
March 31, 2017 | 16.40M |
December 31, 2016 | 19.28M |
September 30, 2016 | 20.45M |
June 30, 2016 | 24.11M |
March 31, 2016 | 23.91M |
December 31, 2015 | 24.78M |
September 30, 2015 | 26.03M |
June 30, 2015 | 25.71M |
March 31, 2015 | 27.55M |
December 31, 2014 | 28.82M |
September 30, 2014 | 30.66M |
June 30, 2014 | 30.88M |
March 31, 2014 | 32.72M |
December 31, 2013 | 35.03M |
September 30, 2013 | 35.34M |
June 30, 2013 | 35.35M |
March 31, 2013 | 38.30M |
December 31, 2012 | 22.66M |
September 30, 2012 | 22.85M |
June 30, 2012 | 22.53M |
March 31, 2012 | 24.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
45.59M
Minimum
Mar 2020
57.46M
Maximum
Jun 2024
50.58M
Average
50.46M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
XWELL Inc | 19.06M |
ProPhase Labs Inc | 49.60M |
Applied DNA Sciences Inc | 4.456M |
Veracyte Inc | 101.80M |
OncoCyte Corp | 52.02M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 214.25M |
Shareholders Equity (Quarterly) | 165.97M |
Debt to Equity Ratio | 0.0007 |
Current Ratio | 7.858 |
Net Debt Paydown Yield | 0.01% |